Compare SBUX & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBUX | HCA |
|---|---|---|
| Founded | 1971 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Hospital/Nursing Management |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9B | 93.7B |
| IPO Year | 1994 | 2009 |
| Metric | SBUX | HCA |
|---|---|---|
| Price | $105.04 | $493.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 35 | 26 |
| Target Price | $110.76 | ★ $475.45 |
| AVG Volume (30 Days) | ★ 9.6M | 1.4M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | ★ 2.37% | 0.61% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | 1.62 | ★ 22.05 |
| Revenue | $37,184,400,000.00 | ★ $75,600,000,000.00 |
| Revenue This Year | N/A | $4.71 |
| Revenue Next Year | $3.92 | $3.16 |
| P/E Ratio | $67.72 | ★ $23.16 |
| Revenue Growth | 2.79 | ★ 7.08 |
| 52 Week Low | $81.97 | $353.99 |
| 52 Week High | $110.51 | $556.52 |
| Indicator | SBUX | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 61.74 |
| Support Level | $101.95 | $425.69 |
| Resistance Level | $109.16 | $512.14 |
| Average True Range (ATR) | 2.83 | 16.50 |
| MACD | 0.67 | 2.72 |
| Stochastic Oscillator | 56.44 | 66.37 |
Starbucks stands out as the world's largest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.